Kymera Investor Day Presentation Deck

Founded 2016 Seed gsk KYMERA Our First 5 Years, a Foundation for the Future Drug Development First In Vitro First Novel Degradation of First In Vivo E3 Novel Target Degradation Degradation 2017 Series A ©2021 KYMERA THERAPEUTICS, INC. 2018 Series B First KYMERA DC First FIRST FIRST EST. 2016 KT-474 IND POM 2019 VERTEX 2020 Series C Financing and Partnerships KYMERA R&D DAY - December 16th, 2021 SANOFI First Transcription Factor POB Degrader IND 2021 IPO FO Molecular Glue Discovery with: A-ALPHA BIO Third Cleared IND in 2021 T NYU W UNIVERSITY of WASHINGTON PAGE 15

View entire presentation